{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:04:32Z","timestamp":1792814672493,"version":"4.5.0"},"reference-count":400,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["232300420049"],"award-info":[{"award-number":["232300420049"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004773","name":"Henan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52373133"],"award-info":[{"award-number":["52373133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52073079"],"award-info":[{"award-number":["52073079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071388"],"award-info":[{"award-number":["32071388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018551","name":"Science and Technology Innovation Talents in Universities of Henan Province","doi-asserted-by":"publisher","award":["24IRTSTHN041"],"award-info":[{"award-number":["24IRTSTHN041"]}],"id":[{"id":"10.13039\/501100018551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.biomaterials.2025.123138","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T18:57:17Z","timestamp":1738090637000},"page":"123138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Advanced nanoparticle engineering for precision therapeutics of brain diseases"],"prefix":"10.1016","volume":"318","author":[{"given":"Muhammad","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2932-1062","authenticated-orcid":false,"given":"Meng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat. Rev. Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123138_bib2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood\u2013brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123138_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Feigin","year":"2019","journal-title":"Lancet Neurol"},{"issue":"10244","key":"10.1016\/j.biomaterials.2025.123138_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(20)31179-X","article-title":"Stroke","volume":"396","author":"Campbell","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123138_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","article-title":"Global, regional, and national burden of stroke, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Johnson","year":"2019","journal-title":"Lancet Neurol."},{"issue":"10145","key":"10.1016\/j.biomaterials.2025.123138_bib6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib7","doi-asserted-by":"crossref","first-page":"e1534","DOI":"10.1016\/S2214-109X(24)00264-X","article-title":"The global macroeconomic burden of alzheimer's disease and other dementias: estimates and projections for 152 countries or territories","volume":"12","author":"Chen","year":"2024","journal-title":"Lancet Glob. Health"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41531-022-00410-y","article-title":"Behalf of the Parkinson's foundation, incidence of Parkinson disease in north America","volume":"8","author":"Willis","year":"2022","journal-title":"NPJ Parkinson's Dis."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123138_bib9","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1021\/acs.biomac.4c00722","article-title":"Stimuli-responsive polymeric nanocarriers accelerate on-demand drug release to combat glioblastoma","volume":"25","author":"Ismail","year":"2024","journal-title":"Biomacromolecules"},{"issue":"29","key":"10.1016\/j.biomaterials.2025.123138_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202314354","article-title":"Bio\u2013nano toolbox for precision alzheimer's disease gene therapy","volume":"36","author":"Liu","year":"2024","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123138_bib11","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1021\/acsnano.6b03858","article-title":"Neuron-targeted nanoparticle for siRNA delivery to traumatic brain injuries","volume":"10","author":"Kwon","year":"2016","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5101\/nbe.v14i1.p71-80","article-title":"Preparation of liposomes coated superparamagnetic iron oxide nanoparticles for targeting and imaging brain glioma","volume":"14","author":"Chen","year":"2022","journal-title":"Nano Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2025.123138_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121608","article-title":"Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma","volume":"287","author":"Ismail","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123138_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121690","article-title":"Blood-brain barrier permeable nanoparticles for alzheimer's disease treatment by selective mitophagy of microglia","volume":"288","author":"Zhong","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123138_bib15","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s11095-013-1289-8","article-title":"Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood\u2013brain barrier","volume":"31","author":"Hsu","year":"2014","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.biomaterials.2025.123138_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114820","article-title":"Engineered nanomaterials that exploit blood-brain barrier dysfunction for delivery to the brain","volume":"197","author":"Wu","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123138_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41578-024-00695-w","article-title":"Precision drug delivery to the central nervous system using engineered nanoparticles","volume":"9","author":"Gao","year":"2024","journal-title":"Nat. Rev. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s44222-023-00138-1","article-title":"Controlling the biodistribution and clearance of nanomedicines","volume":"2","author":"Cabral","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","article-title":"Targeting strategies for tissue-specific drug delivery","volume":"181","author":"Zhao","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib20","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1038\/s41467-022-31882-4","article-title":"Nanoparticle elasticity affects systemic circulation lifetime by modulating adsorption of apolipoprotein A-I in corona formation","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123138_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.biomaterials.2018.08.022","article-title":"The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles","volume":"182","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123138_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.882363","article-title":"Understanding the role and impact of poly(ethylene glycol)(PEG) on nanoparticle formulation: implications for COVID-19 vaccines","volume":"10","author":"Pad\u00edn-Gonz\u00e1lez","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123138_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101536","article-title":"PLGA's plight and the role of stealth surface modification strategies in its use for intravenous particulate drug delivery","volume":"11","author":"Sheffey","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004025","article-title":"Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization, and drug release","volume":"8","author":"Ruan","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2025.123138_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120645","article-title":"An update on actively targeted liposomes in advanced drug delivery to glioma","volume":"602","author":"Mojarad-Jabali","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"21","key":"10.1016\/j.biomaterials.2025.123138_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111654","article-title":"Nanoparticles for targeted brain drug delivery: what do we know?","volume":"22","author":"Pinheiro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2025.123138_bib27","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3762\/bjnano.11.72","article-title":"Key for crossing the BBB with nanoparticles: the rational design","volume":"11","author":"Lombardo","year":"2020","journal-title":"Beilstein J. Nanotechnol."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib29","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1038\/s41467-020-18237-7","article-title":"Mapping and identification of soft corona proteins at nanoparticles and their impact on cellular association","volume":"11","author":"Mohammad-Beigi","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123138_bib30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41551-019-0436-x","article-title":"Engineering patient-specific cancer immunotherapies","volume":"3","author":"Scheetz","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib31","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.1021\/acsnano.8b03500","article-title":"Evolution of nanoparticle protein corona across the blood\u2013brain barrier","volume":"12","author":"Cox","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123138_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.007","article-title":"Emerging well-tailored nanoparticulate delivery system based on in situ regulation of the protein corona","volume":"320","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nnano.2016.269","article-title":"Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo","volume":"12","author":"Chen","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"13","key":"10.1016\/j.biomaterials.2025.123138_bib34","article-title":"Ligand\u2010installed nanocarriers toward precision therapy","volume":"32","author":"Mi","year":"2020","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tibtech.2016.07.006","article-title":"Breaking down the barriers to precision cancer nanomedicine","volume":"35","author":"von Roemeling","year":"2017","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biomaterials.2025.123138_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103046","article-title":"Impact of protein coronas on nanoparticle interactions with tissues and targeted delivery","volume":"85","author":"Chou","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"issue":"52","key":"10.1016\/j.biomaterials.2025.123138_bib37","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123138_bib38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biotechadv.2019.04.012","article-title":"RNAi therapeutic and its innovative biotechnological evolution","volume":"37","author":"Weng","year":"2019","journal-title":"Biotechnol. Adv."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib39","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123138_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123138_bib41","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"issue":"42","key":"10.1016\/j.biomaterials.2025.123138_bib42","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1016\/j.vaccine.2022.08.024","article-title":"mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations","volume":"40","author":"Carre\u00f1o","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2025.123138_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121415","article-title":"Branched PEG-modification: a new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy","volume":"283","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123138_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.127359","article-title":"Hypoxia-degradable zwitterionic phosphorylcholine drug nanogel for enhanced drug delivery to glioblastoma","volume":"408","author":"She","year":"2021","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nantod.2014.02.004","article-title":"Poly(carboxybetaine) nanomaterials enable long circulation and prevent polymer-specific antibody production","volume":"9","author":"Yang","year":"2014","journal-title":"Nano Today"},{"issue":"39","key":"10.1016\/j.biomaterials.2025.123138_bib46","doi-asserted-by":"crossref","first-page":"12046","DOI":"10.1073\/pnas.1512465112","article-title":"Zwitterionic gel encapsulation promotes protein stability, enhances pharmacokinetics, and reduces immunogenicity","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2025.123138_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111541","article-title":"Research progress and application opportunities of nanoparticle\u2013protein corona complexes","volume":"139","author":"Huang","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"27","key":"10.1016\/j.biomaterials.2025.123138_bib48","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"13","key":"10.1016\/j.biomaterials.2025.123138_bib49","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1039\/C7NR09355A","article-title":"Interaction of spin-labeled HPMA-based nanoparticles with human blood plasma proteins \u2013 the introduction of protein-corona-free polymer nanomedicine","volume":"10","author":"Klepac","year":"2018","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib50","article-title":"Immunogenicity of polyethylene glycol based nanomedicines: mechanisms, clinical implications and systematic approach","volume":"3","author":"d'Avanzo","year":"2020","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib51","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1038\/s41467-019-11593-z","article-title":"Brain-targeted drug delivery by manipulating protein corona functions","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2025.123138_bib52","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2018.10.011","article-title":"The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system","volume":"552","author":"Xiao","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123138_bib53","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1039\/D0BM02221G","article-title":"Strategies for the design of nanoparticles: starting with long-circulating nanoparticles, from lab to clinic","volume":"9","author":"Wang","year":"2021","journal-title":"Biomater. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib54","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2025.123138_bib55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2019.07.006","article-title":"Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications","volume":"144","author":"Mohammadpour","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123138_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114238","article-title":"Why nanoparticles prefer liver macrophage cell uptake in vivo","volume":"185","author":"Ngo","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib57","doi-asserted-by":"crossref","first-page":"199","DOI":"10.26599\/NBE.2023.9290024","article-title":"Nanomaterials for targeting liver disease: research progress and future perspectives","volume":"15","author":"Wu","year":"2023","journal-title":"Nano Biomed. Eng."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123138_bib58","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1021\/acsnano.5b04866","article-title":"Soft discoidal polymeric nanoconstructs resist macrophage uptake and enhance vascular targeting in tumors","volume":"9","author":"Key","year":"2015","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib59","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1021\/acsnano.9b03924","article-title":"Role of nanoparticle mechanical properties in cancer drug delivery","volume":"13","author":"Hui","year":"2019","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11095-019-2692-6","article-title":"Quality-by-design concepts to improve nanotechnology-based drug development","volume":"36","author":"Rawal","year":"2019","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.biomaterials.2025.123138_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00027","article-title":"Transporter-guided delivery of nanoparticles to improve drug permeation across cellular barriers and drug exposure to selective cell types","volume":"9","author":"Kou","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib62","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nnano.2017.170","article-title":"Glomerular barrier behaves as an atomically precise bandpass filter in a sub-nanometre regime","volume":"12","author":"Du","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123138_bib63","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41578-018-0038-3","article-title":"Transport and interactions of nanoparticles in the kidneys","volume":"3","author":"Du","year":"2018","journal-title":"Nat. Rev. Mater."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123138_bib64","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2217\/nnm-2018-0040","article-title":"Factors relating to the biodistribution & clearance of nanoparticles & their effects on in vivo application","volume":"13","author":"Wei","year":"2018","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123138_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101090","article-title":"Development of novel therapeutics targeting the blood\u2013brain barrier: from barrier to carrier","volume":"8","author":"Li","year":"2021","journal-title":"Adv. Sci."},{"issue":"7323","key":"10.1016\/j.biomaterials.2025.123138_bib67","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood\u2013brain barrier","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib68","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","article-title":"Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging","volume":"68","author":"Bell","year":"2010","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123138_bib69","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nn.4288","article-title":"Pericytes of the neurovascular unit: key functions and signaling pathways","volume":"19","author":"Sweeney","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"46","key":"10.1016\/j.biomaterials.2025.123138_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood\u2013brain barrier: the role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib71","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1038\/srep04871","article-title":"Margination of micro- and nano-particles in blood flow and its effect on drug delivery","volume":"4","author":"M\u00fcller","year":"2014","journal-title":"Sci. Rep."},{"issue":"32","key":"10.1016\/j.biomaterials.2025.123138_bib72","doi-asserted-by":"crossref","first-page":"15350","DOI":"10.1039\/C8NR04042G","article-title":"Influence of particle size and shape on their margination and wall-adhesion: implications in drug delivery vehicle design across nano-to-micro scale","volume":"10","author":"Cooley","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2025.123138_bib73","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jconrel.2021.05.046","article-title":"Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier","volume":"335","author":"Pathan","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2025.123138_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2020.105493","article-title":"Simulation study of the effects of interstitial fluid pressure and blood flow velocity on transvascular transport of nanoparticles in tumor microenvironment","volume":"193","author":"Gao","year":"2020","journal-title":"Comput. Methods Programs Biomed."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib75","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/1073858418775027","article-title":"Fluid dynamics inside the brain barrier: current concept of interstitial flow, glymphatic flow, and cerebrospinal fluid circulation in the brain","volume":"25","author":"Nakada","year":"2018","journal-title":"Neuroscientist"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1515\/revneuro-2020-0057","article-title":"Exploring the interstitial system in the brain: the last mile of drug delivery","volume":"32","author":"Sun","year":"2021","journal-title":"Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123138_bib77","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/mp300495e","article-title":"Diffusion of macromolecules in the brain: implications for drug delivery","volume":"10","author":"Wolak","year":"2013","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib78","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12989-017-0199-z","article-title":"Mechanistic understanding of nanoparticles' interactions with extracellular matrix: the cell and immune system","volume":"14","author":"Engin","year":"2017","journal-title":"Part. Fibre Toxicol."},{"issue":"21","key":"10.1016\/j.biomaterials.2025.123138_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202209529","article-title":"In response to precision medicine: current subcellular targeting strategies for cancer therapy","volume":"35","author":"Li","year":"2023","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib80","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/es403864v","article-title":"Nanoparticles meet cell membranes: probing nonspecific interactions using model membranes","volume":"48","author":"Chen","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.biomaterials.2025.123138_bib81","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.nantod.2017.04.011","article-title":"Extra-and intra-cellular fate of nanocarriers under dynamic interactions with biology","volume":"14","author":"Seo","year":"2017","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib82","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/acs.jpcb.7b09619","article-title":"Receptor-mediated endocytosis of nanoparticles: roles of shapes, orientations, and rotations of nanoparticles","volume":"122","author":"Tang","year":"2018","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-12-5","article-title":"Engineered nanoparticles interacting with cells: size matters","volume":"12","author":"Shang","year":"2014","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib84","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/cr.2010.19","article-title":"Endocytosis unplugged: multiple ways to enter the cell","volume":"20","author":"Kumari","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.biomaterials.2025.123138_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115239","article-title":"Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release","volume":"207","author":"Liu","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123138_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113451","article-title":"Mitochondrial targeting theranostic nanomedicine and molecular biomarkers for efficient cancer diagnosis and therapy","volume":"153","author":"Rout","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123138_bib87","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib88","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s11671-018-2728-6","article-title":"Insight into cellular uptake and intracellular trafficking of nanoparticles","volume":"13","author":"Foroozandeh","year":"2018","journal-title":"Nanoscale Res. Lett."},{"issue":"82","key":"10.1016\/j.biomaterials.2025.123138_bib89","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2012.0939","article-title":"New views on cellular uptake and trafficking of manufactured nanoparticles","volume":"10","author":"Treuel","year":"2013","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.biomaterials.2025.123138_bib90","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3389\/fphar.2019.00840","article-title":"Microglial drug targets in AD: opportunities and challenges in drug discovery and development","volume":"10","author":"Biber","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biomaterials.2025.123138_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102188","article-title":"Microglia as therapeutic targets for central nervous system remyelination","volume":"63","author":"Mahmood","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib92","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nurt.2010.07.006","article-title":"Functions of astrocytes and their potential as therapeutic targets","volume":"7","author":"Kimelberg","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biomaterials.2025.123138_bib93","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1471-4159.2011.07507.x","article-title":"Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of alzheimer's disease","volume":"120","author":"Fisher","year":"2012","journal-title":"J. Neurochem."},{"issue":"35","key":"10.1016\/j.biomaterials.2025.123138_bib94","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1523\/JNEUROSCI.0873-16.2016","article-title":"Involvement of striatal cholinergic interneurons and M1 and M4 muscarinic receptors in motor symptoms of Parkinson's disease","volume":"36","author":"Ztaou","year":"2016","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib95","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tibtech.2015.10.005","article-title":"Antibody approaches to treat brain diseases","volume":"34","author":"Neves","year":"2016","journal-title":"Trends Biotechnol."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib96","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood-brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123138_bib97","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib98","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/10717544.2020.1831103","article-title":"Cell-mediated targeting drugs delivery systems","volume":"27","author":"Yu","year":"2020","journal-title":"Drug Deliv."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib99","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2025.123138_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-018-0113-6","article-title":"Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood\u2013brain barrier","volume":"15","author":"Hladky","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.biomaterials.2025.123138_bib101","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.addr.2021.02.008","article-title":"Target specific tight junction modulators","volume":"171","author":"Brunner","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123138_bib102","doi-asserted-by":"crossref","DOI":"10.4137\/PMC.S13384","article-title":"Pathways for small molecule delivery to the central nervous system across the blood-brain barrier","volume":"6","author":"Mikitsh","year":"2014","journal-title":"Perspect. Medicin. Chem."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib103","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-022-03241-x","article-title":"Targeting transporters for dug delivery to the brain: can we do better?","volume":"39","author":"Puris","year":"2022","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.biomaterials.2025.123138_bib104","doi-asserted-by":"crossref","unstructured":"X. Zhu, K. Jin, Y. Huang, Z. Pang, 7 - brain drug delivery by adsorption-mediated transcytosis, in: H. Gao, X. Gao (Eds.), Brain Targeted Drug Delivery System, Academic Press2019, pp. 159-183.","DOI":"10.1016\/B978-0-12-814001-7.00007-X"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41467-018-02818-8","article-title":"Membrane bending occurs at all stages of clathrin-coat assembly and defines endocytic dynamics","volume":"9","author":"Scott","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123138_bib106","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.coche.2020.08.009","article-title":"Caveolae-mediated transport at the injured blood-brain barrier as an underexplored pathway for central nervous system drug delivery","volume":"30","author":"Sorets","year":"2020","journal-title":"Curr. Opin. Chem. Eng."},{"issue":"7816","key":"10.1016\/j.biomaterials.2025.123138_bib107","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41586-020-2453-z","article-title":"Physiological blood\u2013brain transport is impaired with age by a shift in transcytosis","volume":"583","author":"Yang","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123138_bib108","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41593-023-01334-3","article-title":"Single-nucleus multiregion transcriptomic analysis of brain vasculature in alzheimer's disease","volume":"26","author":"Sun","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib109","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1038\/s41467-023-44319-3","article-title":"ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2018","journal-title":"Physiol. Rev."},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123138_bib111","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2174\/138161208784705487","article-title":"The role of the cell surface LRP and soluble LRP in blood-brain barrier A\u03b2 clearance in alzheimers disease","volume":"14","author":"Deane","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib112","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/brain\/awac309","article-title":"Cerebrovascular insulin receptors are defective in alzheimer's disease","volume":"146","author":"Leclerc","year":"2023","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib113","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in alzheimer's disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib114","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.apsb.2022.02.001","article-title":"Intelligent lesion blood\u2013brain barrier targeting nano-missiles for alzheimer's disease treatment by anti-neuroinflammation and neuroprotection","volume":"12","author":"He","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123138_bib115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","article-title":"Alpha synuclein is transported into and out of the brain by the blood\u2013brain barrier","volume":"62","author":"Sui","year":"2014","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib116","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1038\/s41598-018-26636-6","article-title":"Metastatic brain tumors disrupt the blood-brain barrier and alter lipid metabolism by inhibiting expression of the endothelial cell fatty acid transporter Mfsd2a","volume":"8","author":"Tiwary","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123138_bib117","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of blood\u2013brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib118","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1080\/10717544.2017.1386731","article-title":"VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy","volume":"24","author":"Wen","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biomaterials.2025.123138_bib119","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25281","article-title":"Co-targeting the tumor endothelium and p-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome","volume":"6","author":"Ferber","year":"2017","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41563-023-01481-9","article-title":"P-selectin-targeted nanocarriers induce active crossing of the blood\u2013brain barrier via caveolin-1-dependent transcytosis","volume":"22","author":"Tylawsky","year":"2023","journal-title":"Nat. Mater."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123138_bib121","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41591-019-0440-4","article-title":"Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1","volume":"25","author":"Yousef","year":"2019","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib122","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/bioengineering11030200","article-title":"Engineered dual antioxidant enzyme complexes targeting ICAM-1 on brain endothelium reduce brain injury-associated neuroinflammation","volume":"11","author":"Leonard","year":"2024","journal-title":"Bioengineering"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib123","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1038\/s41598-017-03309-4","article-title":"Acute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury","volume":"7","author":"Lutton","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2025.123138_bib124","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biomaterials.2017.10.012","article-title":"Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy","volume":"150","author":"Tian","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123138_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.605398","article-title":"Blood-brain barrier damage in ischemic stroke and its regulation by endothelial mechanotransduction","volume":"11","author":"Nian","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biomaterials.2025.123138_bib126","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2019.03.008","article-title":"Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain","volume":"301","author":"Marcos-Contreras","year":"2019","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib127","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.1912012117","article-title":"Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood\u2013brain barrier","volume":"117","author":"Marcos-Contreras","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12987-015-0016-8","article-title":"Endotoxin-induced inflammation down-regulates l-type amino acid transporter 1 (LAT1) expression at the blood\u2013brain barrier of male rats and mice","volume":"12","author":"Wittmann","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.biomaterials.2025.123138_bib129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00401-011-0883-2","article-title":"Claudin-1 induced sealing of blood\u2013brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis","volume":"122","author":"Pfeiffer","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1523\/JNEUROSCI.1432-18.2018","article-title":"Claudin-1-dependent destabilization of the blood\u2013brain barrier in chronic stroke","volume":"39","author":"Sladojevic","year":"2019","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib131","doi-asserted-by":"crossref","first-page":"18520","DOI":"10.1021\/acsnano.1c08432","article-title":"Claudin-1-targeted nanoparticles for delivery to aging-induced alterations in the blood\u2013brain barrier","volume":"15","author":"Bony","year":"2021","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib132","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1039\/D4SD00063C","article-title":"Optimized gadolinium-DO3A loading in RAFT-polymerized copolymers for superior MR imaging of aging blood\u2013brain barrier","volume":"3","author":"Miller","year":"2024","journal-title":"Sens. Diagn"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib133","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082331","article-title":"Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)","volume":"9","author":"Gaillard","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib135","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/jps.23994","article-title":"Enhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic caelyx,\u00ae\/doxil\u00ae\u2014a cerebral open flow microperfusion pilot study","volume":"103","author":"Birngruber","year":"2014","journal-title":"Braz. J. Pharm. Sci."},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123138_bib136","article-title":"Abstract CT216: phase I dose escalating study of 2B3-101, glutathione PEGylated liposomal doxorubicin, in patients with solid tumors and brain metastases or recurrent malignant glioma","volume":"74","author":"Gaillard","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib137","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1158\/1078-0432.CCR-19-1834","article-title":"Ultrasmall core-shell silica nanoparticles for precision drug delivery in a high-grade malignant brain tumor model","volume":"26","author":"Juthani","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib138","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1474-4422(12)70225-9","article-title":"Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"11","author":"Hill","year":"2012","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gendis.2017.01.004","article-title":"Targeting metastatic breast cancer with ANG1005, a novel peptide-paclitaxel conjugate that crosses the blood-brain-barrier (BBB)","volume":"4","author":"Li","year":"2017","journal-title":"Genes Dis"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib140","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymthe.2018.12.005","article-title":"Iduronate-2-sulfatase with anti-human transferrin receptor antibody for neuropathic mucopolysaccharidosis II: a phase 1\/2 trial","volume":"27","author":"Okuyama","year":"2019","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib141","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1039\/C7RA12376K","article-title":"Facile construction of dual-targeting delivery system by using lipid capped polymer nanoparticles for anti-glioma therapy","volume":"8","author":"Wang","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.biomaterials.2025.123138_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121760","article-title":"Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in cu-loaded glioblastoma resulting in potent growth inhibition","volume":"289","author":"Ismail","year":"2022","journal-title":"Biomaterials"},{"issue":"5990","key":"10.1016\/j.biomaterials.2025.123138_bib143","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123138_bib144","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0361-9230(88)90021-4","article-title":"Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier","volume":"21","author":"Banks","year":"1988","journal-title":"Brain Res. Bull."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib145","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1073\/pnas.88.11.4771","article-title":"Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier","volume":"88","author":"Friden","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib146","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1021\/acs.molpharmaceut.8b00730","article-title":"Blood-brain barrier transport, plasma pharmacokinetics, and neuropathology following chronic treatment of the rhesus monkey with a brain penetrating humanized monoclonal antibody against the human transferrin receptor","volume":"15","author":"Pardridge","year":"2018","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123138_bib147","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1039\/D2BM02152H","article-title":"Transferrin receptor 1 targeted nanomedicine for brain tumor therapy","volume":"11","author":"Li","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biomaterials.2025.123138_bib148","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.colsurfb.2016.04.041","article-title":"Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for alzheimer's disease treatment","volume":"145","author":"Loureiro","year":"2016","journal-title":"Colloids Surf., B"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib149","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1871527321666220222092655","article-title":"Nanoparticles as powerful tools for crossing the blood-brain barrier","volume":"22","author":"Hasannejad-Asl","year":"2023","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.biomaterials.2025.123138_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112999","article-title":"Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): a current overview of active targeting in brain diseases","volume":"221","author":"Teixeira","year":"2023","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.biomaterials.2025.123138_bib151","first-page":"112","article-title":"Overcoming blood\u2013brain barrier transport: advances in nanoparticle-based drug delivery strategies, Mater","volume":"37","author":"Ding","year":"2020","journal-title":"Today Off."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib152","article-title":"Brain co-delivery of first-line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy","volume":"2","author":"Liu","year":"2022","journal-title":"Exploration"},{"key":"10.1016\/j.biomaterials.2025.123138_bib153","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.actbio.2016.03.038","article-title":"Zwitterionic materials for antifouling membrane surface construction","volume":"40","author":"He","year":"2016","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib154","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/adma.201404059","article-title":"Molecular understanding and design of zwitterionic materials","volume":"27","author":"Shao","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123138_bib155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2015.07.014","article-title":"Nanocarriers with tunable surface properties to unblock bottlenecks in systemic drug and gene delivery","volume":"214","author":"Zou","year":"2015","journal-title":"J. Control. Release"},{"issue":"32","key":"10.1016\/j.biomaterials.2025.123138_bib156","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1016\/j.biomaterials.2007.07.046","article-title":"In vivo biological evaluation of high molecular weight hyperbranched polyglycerols","volume":"28","author":"Kainthan","year":"2007","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib157","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1021\/nn304045q","article-title":"PEG-stabilized core\u2013shell nanoparticles: impact of linear versus dendritic polymer shell architecture on colloidal properties and the reversibility of temperature-induced aggregation","volume":"7","author":"Gillich","year":"2013","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib158","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated liposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"30","key":"10.1016\/j.biomaterials.2025.123138_bib159","doi-asserted-by":"crossref","first-page":"16881","DOI":"10.1021\/acsami.5b05627","article-title":"Probing the surface hydration of nonfouling zwitterionic and PEG materials in contact with proteins","volume":"7","author":"Leng","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2025.123138_bib160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.actbio.2016.03.009","article-title":"Salt-responsive polyzwitterionic materials for surface regeneration between switchable fouling and antifouling properties","volume":"40","author":"Chen","year":"2016","journal-title":"Acta Biomater."},{"issue":"33","key":"10.1016\/j.biomaterials.2025.123138_bib161","doi-asserted-by":"crossref","first-page":"9125","DOI":"10.1021\/acs.langmuir.5b02119","article-title":"Salt-responsive zwitterionic polymer brushes with tunable friction and antifouling properties","volume":"31","author":"Yang","year":"2015","journal-title":"Langmuir"},{"issue":"44","key":"10.1016\/j.biomaterials.2025.123138_bib162","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1039\/C5SM01962A","article-title":"Polyelectrolyte brushes: theory, modelling, synthesis and applications","volume":"11","author":"Das","year":"2015","journal-title":"Soft Matter"},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123138_bib163","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1039\/D1BM00570G","article-title":"Synthesis of poly(2-methacryloyloxyethyl phosphorylcholine)-conjugated lipids and their characterization and surface properties of modified liposomes for protein interactions","volume":"9","author":"Adler","year":"2021","journal-title":"Biomater. Sci."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123138_bib164","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1021\/acs.biomac.3c00649","article-title":"Zwitterionic polymer-decorated lipid nanoparticles for mRNA delivery in mammalian cells","volume":"24","author":"Khunsuk","year":"2023","journal-title":"Biomacromolecules"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123138_bib165","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/bjp.2008.185","article-title":"Acetylcholine beyond neurons: the non\u2010neuronal cholinergic system in humans","volume":"154","author":"Wessler","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123138_bib166","article-title":"A bioinspired platform for effective delivery of protein therapeutics to the central nervous system","volume":"31","author":"Wu","year":"2019","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123138_bib167","article-title":"Systemic delivery of monoclonal antibodies to the central nervous system for brain tumor therapy","volume":"31","author":"Han","year":"2019","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib168","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41551-019-0434-z","article-title":"Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice","volume":"3","author":"Wen","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"33","key":"10.1016\/j.biomaterials.2025.123138_bib169","article-title":"Efficient delivery of nerve growth factors to the central nervous system for neural regeneration","volume":"31","author":"Xu","year":"2019","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib170","doi-asserted-by":"crossref","first-page":"8287","DOI":"10.1021\/acsnano.0c01870","article-title":"Polymersomes eradicating intracellular bacteria","volume":"14","author":"Fenaroli","year":"2020","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib171","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/mp400610b","article-title":"Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluation","volume":"11","author":"Colley","year":"2014","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib172","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1021\/acscentsci.2c00146","article-title":"A multiscale study of phosphorylcholine driven cellular phenotypic targeting","volume":"8","author":"Acosta-Guti\u00e9rrez","year":"2022","journal-title":"ACS Cent. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib173","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000207","article-title":"Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery","volume":"8","author":"Zheng","year":"2020","journal-title":"J. ImmunoTher. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib174","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/acsnano.1c08120","article-title":"Smart nanomedicine to enable crossing blood\u2013brain barrier delivery of checkpoint blockade antibody for immunotherapy of glioma","volume":"16","author":"Wang","year":"2022","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib175","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202105711","article-title":"Self\u2010catalytic small interfering RNA nanocarriers for synergistic treatment of neurodegenerative diseases","volume":"34","author":"Ji","year":"2022","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123138_bib176","doi-asserted-by":"crossref","DOI":"10.1002\/ange.202201390","article-title":"Fluorination and betaine modification augment the blood\u2013brain barrier\u2010crossing ability of cylindrical polymer brushes","volume":"134","author":"Wang","year":"2022","journal-title":"Angew. Chem."},{"key":"10.1016\/j.biomaterials.2025.123138_bib177","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2023.10.019","article-title":"Super-small zwitterionic micelles enable the improvement of blood-brain barrier crossing for efficient orthotopic glioblastoma combinational therapy","volume":"364","author":"Wang","year":"2023","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123138_bib178","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201705054","article-title":"Traceable nanoparticles with dual targeting and ROS response for RNAi-based immunochemotherapy of intracranial glioblastoma treatment","volume":"30","author":"Qiao","year":"2018","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib179","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201901555","article-title":"An \u201camyloid-\u03b2 cleaner\u201d for the treatment of alzheimer's disease by normalizing microglial dysfunction","volume":"7","author":"Liu","year":"2020","journal-title":"Adv. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib180","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1039\/C9MH00482C","article-title":"Switchable nanoparticle for programmed gene-chem delivery with enhanced neuronal recovery and CT imaging for neurodegenerative disease treatment","volume":"6","author":"Liu","year":"2019","journal-title":"Mater. Horiz."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib181","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202308251","article-title":"Cyclic peptides for drug development","volume":"63","author":"Ji","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123138_bib182","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.drudis.2021.02.008","article-title":"LDL receptors and their role in targeted therapy for glioma: a review","volume":"26","author":"Pawar","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib183","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1021\/acsnano.2c00320","article-title":"Brain-targeted codelivery of Bcl-2\/Bcl-xl and Mcl-1 inhibitors by biomimetic nanoparticles for orthotopic glioblastoma therapy","volume":"16","author":"He","year":"2022","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib184","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/acsnano.8b05265","article-title":"Apolipoprotein E peptide-directed chimeric polymersomes mediate an ultrahigh-efficiency targeted protein therapy for glioblastoma","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib185","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41467-023-35957-8","article-title":"Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.biomaterials.2025.123138_bib186","article-title":"A brain-targeting NIR-II ferroptosis system: effective visualization and oncotherapy for orthotopic glioblastoma","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123138_bib187","doi-asserted-by":"crossref","first-page":"16840","DOI":"10.1021\/acsnano.3c03724","article-title":"Dual-site f\u00f6rster resonance energy transfer route of upconversion nanoparticles-based brain-targeted nanotheranostic boosts the near-infrared phototherapy of glioma","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"issue":"29","key":"10.1016\/j.biomaterials.2025.123138_bib188","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202400502","article-title":"Dual-targeted novel temozolomide nanocapsules encapsulating siPKM2 inhibit aerobic glycolysis to sensitize glioblastoma to chemotherapy","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123138_bib189","doi-asserted-by":"crossref","first-page":"13283","DOI":"10.1007\/s12274-023-5921-6","article-title":"Glioblastoma cell-derived exosomes functionalized with peptides as efficient nanocarriers for synergistic chemotherapy of glioblastoma with improved biosafety","volume":"16","author":"Zhou","year":"2023","journal-title":"Nano Res."},{"issue":"39","key":"10.1016\/j.biomaterials.2025.123138_bib190","doi-asserted-by":"crossref","first-page":"14789","DOI":"10.1039\/D2NR03683E","article-title":"Angiopep-2-decorated titanium\u2013alloy core\u2013shell magnetic nanoparticles for nanotheranostics and medical imaging","volume":"14","author":"Thirumurugan","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2025.123138_bib191","article-title":"Lipid\u2010polymer nanoparticles mediate compartmentalized delivery of Cas9 and sgRNA for glioblastoma vasculature and immune reprogramming","author":"Zhang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2025.123138_bib192","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jconrel.2022.09.046","article-title":"Brain-targeted CRISPR\/Cas9 nanomedicine for effective glioblastoma therapy","volume":"351","author":"Ruan","year":"2022","journal-title":"J. Control. Release"},{"issue":"37","key":"10.1016\/j.biomaterials.2025.123138_bib193","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201903277","article-title":"ROS-responsive polymeric siRNA nanomedicine stabilized by triple interactions for the robust glioblastoma combinational RNAi therapy","volume":"31","author":"Zheng","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123138_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121036","article-title":"Polymeric nanoparticle mediated inhibition of miR-21 with enhanced miR-124 expression for combinatorial glioblastoma therapy","volume":"276","author":"Liu","year":"2021","journal-title":"Biomaterials"},{"issue":"24","key":"10.1016\/j.biomaterials.2025.123138_bib195","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202000416","article-title":"Single siRNA nanocapsules for effective siRNA brain delivery and glioblastoma treatment","volume":"32","author":"Zou","year":"2020","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123138_bib196","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1021\/acsnano.3c11958","article-title":"Cathepsin B-responsive programmed brain targeted delivery system for chemo-immunotherapy combination therapy of glioblastoma","volume":"18","author":"Jiang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123138_bib197","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2024.02.039","article-title":"Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke","volume":"368","author":"Li","year":"2024","journal-title":"J. Control. Release"},{"issue":"22","key":"10.1016\/j.biomaterials.2025.123138_bib198","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202300029","article-title":"Stimuli-responsive multifunctional nanomedicine for enhanced glioblastoma chemotherapy augments multistage blood-to-brain trafficking and tumor targeting","volume":"19","author":"Martins","year":"2023","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib199","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0271678X18808399","article-title":"Mechanisms of glutathione-conjugate efflux from the brain into blood: involvement of multiple transporters in the course","volume":"40","author":"Okamura","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.biomaterials.2025.123138_bib200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ddtec.2016.09.003","article-title":"Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo","volume":"20","author":"Maussang","year":"2016","journal-title":"Drug Discov. Today Technol."},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123138_bib201","doi-asserted-by":"crossref","first-page":"15724","DOI":"10.1021\/acsnano.3c03232","article-title":"MTOR-mediated immunometabolic reprogramming nanomodulators enable sensitive switching of energy deprivation-induced microglial polarization for alzheimer's disease management","volume":"17","author":"Yang","year":"2023","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib202","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1021\/acsbiomaterials.8b01420","article-title":"Glutathione (GSH) peptide conjugated magnetic nanoparticles as blood\u2013brain barrier shuttle for MRI-monitored brain delivery of paclitaxel","volume":"5","author":"Nosrati","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123138_bib203","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/j.clinthera.2015.05.232","article-title":"double-blind, placebo and active comparator-controlled study in healthy males followed by an open-label study in healty males and females, to asses the safety, pharmacokinetics and \u2013dynamics of 2B3-201","volume":"37","author":"Kanhai","year":"2015","journal-title":"Clin. Ther."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123138_bib204","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292681","article-title":"TAT peptide at treatment-level concentrations crossed brain endothelial cell monolayer independent of receptor-mediated endocytosis or peptide-inflicted barrier disruption","volume":"18","author":"Wu","year":"2023","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib205","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1074\/jbc.M110017200","article-title":"Possible existence of common internalization mechanisms among arginine-rich peptides","volume":"277","author":"Suzuki","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.biomaterials.2025.123138_bib206","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1016\/j.biomaterials.2008.08.004","article-title":"TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs","volume":"29","author":"Rao","year":"2008","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib207","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12951-021-01002-3","article-title":"Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"29","key":"10.1016\/j.biomaterials.2025.123138_bib208","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202300395","article-title":"Calcium Phosphate\u2010based nanoformulation selectively abolishes phenytoin resistance in epileptic neurons for ceasing seizures","volume":"19","author":"Guan","year":"2023","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib209","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1021\/acs.molpharmaceut.2c00755","article-title":"Enhancing methotrexate delivery in the brain by mesoporous silica nanoparticles functionalized with cell-penetrating peptide using in vivo and ex vivo monitoring","volume":"20","author":"Shadmani","year":"2023","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123138_bib210","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1021\/acsnano.2c11363","article-title":"Reactive oxygen species-responsive transformable and triple-targeting butylphthalide nanotherapy for precision treatment of ischemic stroke by normalizing the pathological microenvironment","volume":"17","author":"Yang","year":"2023","journal-title":"ACS Nano"},{"issue":"36","key":"10.1016\/j.biomaterials.2025.123138_bib211","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202401173","article-title":"Brain-targeted 9-phenanthrol-loaded lipid nanoparticle prevents brain edema after cerebral ischemia-reperfusion injury by inhibiting the trpm4 channel in mice","volume":"34","author":"Liu","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib212","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1021\/acsami.8b16219","article-title":"D-T7 Peptide-modified PEGylated bilirubin nanoparticles loaded with cediranib and paclitaxel for antiangiogenesis and chemotherapy of glioma","volume":"11","author":"Yu","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib213","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1016\/j.apsb.2022.05.016","article-title":"Dual-targeting prodrug nanotheranostics for NIR-\u2161 fluorescence imaging-guided photo-immunotherapy of glioblastoma","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123138_bib214","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2018.04.034","article-title":"Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of alzheimer's disease","volume":"279","author":"Wang","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2025.123138_bib215","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jconrel.2023.01.074","article-title":"Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of alzheimer's disease","volume":"355","author":"Guo","year":"2023","journal-title":"J. Control. Release"},{"issue":"37","key":"10.1016\/j.biomaterials.2025.123138_bib216","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202300570","article-title":"Hsp70\u2010targeting and size\u2010tunable nanoparticles combine with PD\u20101 checkpoint blockade to treat glioma","volume":"19","author":"Xie","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2025.123138_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.150525","article-title":"A novel brain targeting MnOx-based MI-3 nanoplatform for immunogenic cell death initiated high-efficiency antitumor immunity against orthotopic glioblastoma","volume":"487","author":"Wang","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biomaterials.2025.123138_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.141606","article-title":"Stimulus-responsive curcumin-based polydopamine nanoparticles for targeting Parkinson's disease by modulating \u03b1-synuclein aggregation and reactive oxygen species","volume":"461","author":"Lei","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123138_bib219","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1021\/acsnano.7b08172","article-title":"Targeted brain delivery of rabies virus glycoprotein 29-modified deferoxamine-loaded nanoparticles reverses functional deficits in parkinsonian mice","volume":"12","author":"You","year":"2018","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib220","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1021\/acsnano.2c05795","article-title":"Cholinergic neuron targeting nanosystem delivering hybrid peptide for combinatorial mitochondrial therapy in alzheimer's disease","volume":"16","author":"Qian","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123138_bib221","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbae015","article-title":"A transferrin receptor targeting dual-modal MR\/NIR fluorescent imaging probe for glioblastoma diagnosis","volume":"11","author":"Hao","year":"2024","journal-title":"Regen. Biomater."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib222","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj4260","article-title":"Targeting pyroptosis with nanoparticles to alleviate neuroinflammatory for preventing secondary damage following traumatic brain injury","volume":"10","author":"Zhang","year":"2024","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib223","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1242\/jcs.104.2.521","article-title":"Receptor-mediated endocytosis of transferrin at the blood-brain barrier","volume":"104","author":"Roberts","year":"1993","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biomaterials.2025.123138_bib224","article-title":"Pathophysiological aspects of transferrin-a potential nano-based drug delivery signaling molecule in therapeutic target for varied diseases","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib225","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-020-03527-3","article-title":"Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models","volume":"148","author":"Ni","year":"2020","journal-title":"J. Neuro Oncol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib226","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3109\/10717544.2016.1162878","article-title":"Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics","volume":"23","author":"Sonali","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biomaterials.2025.123138_bib227","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2018.03.006","article-title":"Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma","volume":"277","author":"Jhaveri","year":"2018","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib228","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/s41467-018-04315-4","article-title":"Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles","volume":"9","author":"Lam","year":"2018","journal-title":"Nat. Commun."},{"issue":"51","key":"10.1016\/j.biomaterials.2025.123138_bib229","article-title":"Brain-targeted liposomes loaded with monoclonal antibodies reduce alpha-synuclein aggregation and improve behavioral symptoms in Parkinson's disease","volume":"35","author":"Sela","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123138_bib230","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jconrel.2024.03.020","article-title":"Rotor-based image-guided therapy of glioblastoma","volume":"368","author":"Pan","year":"2024","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123138_bib231","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.nbt.2014.12.006","article-title":"Ferritin family proteins and their use in bionanotechnology","volume":"32","author":"He","year":"2015","journal-title":"N. Biotechnol."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib232","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.it.2007.07.011","article-title":"Immunogenicity of protein therapeutics","volume":"28","author":"De Groot","year":"2007","journal-title":"Trends Immunol."},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123138_bib233","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1021\/acs.jafc.3c09903","article-title":"Advancements of the molecular directed design and structure\u2013activity relationship of ferritin nanocage","volume":"72","author":"Xia","year":"2024","journal-title":"J. Agric. Food Chem."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib234","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1021\/acs.molpharmaceut.7b00341","article-title":"Apoferritin nanocage for brain targeted doxorubicin delivery","volume":"14","author":"Chen","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123138_bib235","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2019.12.010","article-title":"Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment","volume":"323","author":"Liu","year":"2020","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib236","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/19390211.2021.1922567","article-title":"Lactoferrin for mental health: neuro-redox regulation and neuroprotective effects across the blood-brain barrier with special reference to neuro-COVID-19","volume":"20","author":"Naidu","year":"2023","journal-title":"J. Diet. Suppl."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib237","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3390\/biom10030456","article-title":"Lactoferrin's anti-cancer properties: safety, selectivity, and wide range of action","volume":"10","author":"Cutone","year":"2020","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123138_bib238","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1021\/acs.molpharmaceut.8b00537","article-title":"Boosted memory and improved brain bioavailability of rivastigmine: targeting effort to the brain using covalently tethered lower generation PAMAM dendrimers with lactoferrin","volume":"15","author":"Gothwal","year":"2018","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib239","doi-asserted-by":"crossref","first-page":"11355","DOI":"10.1021\/acsnano.8b06201","article-title":"Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors","volume":"12","author":"Shen","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123138_bib240","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijbiomac.2017.08.155","article-title":"Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma","volume":"107","author":"Li","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"6109","key":"10.1016\/j.biomaterials.2025.123138_bib241","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1126\/science.1226338","article-title":"Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities","volume":"338","author":"Cheng","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2025.123138_bib242","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2019.01.005","article-title":"Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo","volume":"295","author":"Johnsen","year":"2019","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib243","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.biomaterials.2007.09.024","article-title":"The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain","volume":"29","author":"Huang","year":"2008","journal-title":"Biomaterials"},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123138_bib244","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201903759","article-title":"Sequential targeting in crosslinking nanotheranostics for tackling the multibarriers of brain tumors","volume":"32","author":"Wu","year":"2020","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib245","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41467-017-00952-3","article-title":"Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain","volume":"8","author":"Anraku","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib246","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1021\/acsnano.3c09817","article-title":"Targeted mRNA nanoparticles ameliorate blood\u2013brain barrier disruption postischemic stroke by modulating microglia polarization","volume":"18","author":"Gao","year":"2024","journal-title":"ACS Nano"},{"issue":"41","key":"10.1016\/j.biomaterials.2025.123138_bib247","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc7031","article-title":"Blood-brain barrier\u2013penetrating siRNA nanomedicine for alzheimer's disease therapy","volume":"6","author":"Zhou","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib248","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41427-019-0138-6","article-title":"Menthol-modified BSA nanoparticles for glioma targeting therapy using an energy restriction strategy","volume":"11","author":"Liang","year":"2019","journal-title":"NPG Asia Mater."},{"key":"10.1016\/j.biomaterials.2025.123138_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119326","article-title":"Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases","volume":"274","author":"Anthony","year":"2021","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib250","article-title":"Functionalized lipid nanoparticles modulate the blood-brain barrier and eliminate \u03b1-synuclein to repair dopamine neurons","volume":"19","author":"Wu","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib251","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41551-021-00803-z","article-title":"Conjugation of glucosylated polymer chains to checkpoint blockade antibodies augments their efficacy and specificity for glioblastoma","volume":"5","author":"Yang","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123138_bib252","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1021\/acsnano.9b09991","article-title":"Dual-sensitive nanomicelles enhancing systemic delivery of therapeutically active antibodies specifically into the brain","volume":"14","author":"Xie","year":"2020","journal-title":"ACS Nano"},{"issue":"21","key":"10.1016\/j.biomaterials.2025.123138_bib253","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1002\/anie.201914751","article-title":"Systemic brain delivery of antisense oligonucleotides across the blood-brain barrier with a glucose-coated polymeric nanocarrier","volume":"59","author":"Min","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123138_bib254","doi-asserted-by":"crossref","first-page":"10356","DOI":"10.1021\/acsami.2c19285","article-title":"Cascade-responsive 2-DG nanocapsules encapsulate aV-siCPT1C conjugates to inhibit glioblastoma through multiple inhibition of energy metabolism","volume":"15","author":"Zhang","year":"2023","journal-title":"ACS Appl. Mater."},{"key":"10.1016\/j.biomaterials.2025.123138_bib255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104633","article-title":"Functionalized curcumin\/ginsenoside Rb1 dual-loaded liposomes: targeting the blood-brain barrier and improving pathological features associated in APP\/PS-1 mice","volume":"86","author":"Yan","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"30","key":"10.1016\/j.biomaterials.2025.123138_bib256","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201802227","article-title":"Acid-responsive transferrin dissociation and GLUT mediated exocytosis for increased blood\u2013brain barrier transcytosis and programmed glioma targeting delivery","volume":"28","author":"Ruan","year":"2018","journal-title":"Adv. Funct. Mater."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib257","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1021\/acs.molpharmaceut.7b00572","article-title":"Regulation of reduced folate carrier (RFC) by vitamin D receptor at the blood-brain barrier","volume":"14","author":"Alam","year":"2017","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib258","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1039\/C9NA00056A","article-title":"Dual targeting of folate receptor-expressing glioma tumor-associated macrophages and epithelial cells in the brain using a carbon nanosphere\u2013cationic folate nanoconjugate","volume":"1","author":"Elechalawar","year":"2019","journal-title":"Nanoscale Adv."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib259","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ddr.21545","article-title":"Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems","volume":"80","author":"Narmani","year":"2019","journal-title":"Drug Dev. Res."},{"issue":"43","key":"10.1016\/j.biomaterials.2025.123138_bib260","doi-asserted-by":"crossref","first-page":"39633","DOI":"10.1021\/acsami.9b14659","article-title":"Folate receptor \u03b1-modified nanoparticles for targeting of the central nervous system","volume":"11","author":"Kuplennik","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"31","key":"10.1016\/j.biomaterials.2025.123138_bib261","doi-asserted-by":"crossref","first-page":"28165","DOI":"10.1021\/acsomega.3c01375","article-title":"Surface-modified biobased polymeric nanoparticles for dual delivery of doxorubicin and gefitinib in glioma cell lines","volume":"8","author":"Farheen","year":"2023","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib262","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1007\/s11426-023-1684-5","article-title":"Engineering blood-brain barrier-permeable and tumor cell-ingestible pro-proteins for glioblastoma treatment","volume":"66","author":"Liu","year":"2023","journal-title":"Sci. China Chem."},{"issue":"36","key":"10.1016\/j.biomaterials.2025.123138_bib263","doi-asserted-by":"crossref","first-page":"30201","DOI":"10.1021\/acsami.8b11782","article-title":"Natural brain penetration enhancer-modified albumin nanoparticles for glioma targeting delivery","volume":"10","author":"Liang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib264","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.apsb.2019.01.006","article-title":"Menthol-modified casein nanoparticles loading 10-hydroxycamptothecin for glioma targeting therapy","volume":"9","author":"Gao","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123138_bib265","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1080\/13880209.2016.1199044","article-title":"Borneol increases blood\u2013tumour barrier permeability by regulating the expression levels of tight junction-associated proteins","volume":"54","author":"Duan","year":"2016","journal-title":"Pharm. Biol."},{"issue":"30","key":"10.1016\/j.biomaterials.2025.123138_bib266","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb4429","article-title":"Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection","volume":"6","author":"Ma","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib267","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1038\/s41467-024-48461-4","article-title":"Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles","volume":"15","author":"Bian","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123138_bib268","first-page":"1","volume":"13","author":"Giugliani","year":"2018","journal-title":"Rare Dis."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123138_bib269","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40259-018-0309-y","article-title":"Emerging technologies for delivery of biotherapeutics and gene therapy across the blood\u2013brain barrier","volume":"32","author":"Stanimirovic","year":"2018","journal-title":"BioDrugs"},{"issue":"37","key":"10.1016\/j.biomaterials.2025.123138_bib270","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1039\/C7TB01385J","article-title":"Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting","volume":"5","author":"Bouchoucha","year":"2017","journal-title":"J. Mater. Chem. B"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123138_bib271","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.7150\/thno.41322","article-title":"Muscone\/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma","volume":"10","author":"Kang","year":"2020","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib272","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1021\/acs.molpharmaceut.5b00597","article-title":"Trafficking of gold nanoparticles coated with the 8D3 anti-transferrin receptor antibody at the mouse blood\u2013brain barrier","volume":"12","author":"Cabez\u00f3n","year":"2015","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib273","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/s41467-019-11719-3","article-title":"Blood\u2013brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy","volume":"10","author":"Galstyan","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib274","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/s41467-023-37632-4","article-title":"Targeting neuronal lysosomal dysfunction caused by \u03b2-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct","volume":"14","author":"Gehrlein","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib275","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s11095-022-03186-1","article-title":"Antibody-targeted liposomes for enhanced targeting of the blood-brain barrier","volume":"39","author":"Ye","year":"2022","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib276","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/cns.12866","article-title":"Insulin receptor in the brain: mechanisms of activation and the role in the CNS pathology and treatment","volume":"24","author":"Pomytkin","year":"2018","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib277","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1179\/1743132812Y.0000000127","article-title":"Atorvastatin and pitavastatin reduce oxidative stress and improve IR\/LDL-R signals in alzheimer's disease","volume":"35","author":"Kurata","year":"2013","journal-title":"Neurol. Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib278","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejpb.2014.05.021","article-title":"Polymersomes conjugated to 83-14 monoclonal antibodies: in vitro targeting of brain capillary endothelial cells","volume":"88","author":"Dieu","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib279","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s11095-006-0274-x","article-title":"Decline in exogenous gene expression in primate brain following intravenous administration is due to plasmid degradation","volume":"23","author":"Chu","year":"2006","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib280","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10611861003734001","article-title":"Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB)","volume":"19","author":"Ulbrich","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.biomaterials.2025.123138_bib281","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuropharm.2016.03.014","article-title":"Antibody therapies in CNS diseases","volume":"120","author":"Freskg\u00e5rd","year":"2017","journal-title":"Neuropharmacol"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib282","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/acs.molpharmaceut.6b01166","article-title":"Brain and organ uptake in the rhesus monkey in vivo of recombinant iduronidase compared to an insulin receptor antibody-iduronidase fusion protein","volume":"14","author":"Boado","year":"2017","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib283","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40259-018-0264-7","article-title":"Plasma pharmacokinetics of valanafusp alpha, a human insulin receptor antibody-iduronidase fusion protein, in patients with mucopolysaccharidosis type I","volume":"32","author":"Pardridge","year":"2018","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib284","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55136-4","article-title":"Bi-functional IgG-lysosomal enzyme fusion proteins for brain drug delivery","volume":"9","author":"Boado","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib285","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/mthe.2002.0633","article-title":"Antisense gene therapy of brain cancer with an artificial virus gene delivery system","volume":"6","author":"Zhang","year":"2002","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib286","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113392","article-title":"Integrative multi-omic profiling of adult mouse brain endothelial cells and potential implications in alzheimer's disease","volume":"42","author":"Yu","year":"2023","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123138_bib287","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.euroneuro.2014.01.020","article-title":"Insulin and insulin-like growth factor receptors in the brain: physiological and pathological aspects","volume":"24","author":"Werner","year":"2014","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib288","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1038\/s41598-021-83198-w","article-title":"Defining the epitope of a blood\u2013brain barrier crossing single domain antibody specific for the type 1 insulin-like growth factor receptor","volume":"11","author":"Sheff","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib289","article-title":"Grabody B, an IGF1 receptor-based shuttle, mediates efficient delivery of biologics across the blood-brain barrier","volume":"2","author":"Shin","year":"2022","journal-title":"Cell Rep. Methods"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib290","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101644R","article-title":"Targeting insulin-like growth factor-1 receptor (IGF1R) for brain delivery of biologics","volume":"36","author":"Alata","year":"2022","journal-title":"FASEB J"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib291","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/pharmaceutics14071452","article-title":"Brain delivery of IGF1R5, a single-domain antibody targeting insulin-like growth factor-1 receptor","volume":"14","author":"Yogi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123138_bib292","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jconrel.2017.11.026","article-title":"Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells","volume":"269","author":"Kim","year":"2018","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123138_bib293","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ultrasmedbio.2021.01.014","article-title":"Focused ultrasound and microbubble treatment increases delivery of transferrin receptor-targeting liposomes to the brain","volume":"47","author":"Olsman","year":"2021","journal-title":"Ultrasound Med. Biol."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123138_bib294","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.apsb.2021.01.020","article-title":"Cell membrane-derived vesicles for delivery of therapeutic agents","volume":"11","author":"Le","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123138_bib295","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.7150\/thno.20118","article-title":"Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy","volume":"7","author":"Zhai","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2025.123138_bib296","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.05.028","article-title":"Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy","volume":"112","author":"Chen","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2025.123138_bib297","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.addr.2020.06.024","article-title":"Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications","volume":"156","author":"Chung","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123138_bib298","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ymeth.2019.12.004","article-title":"Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications","volume":"177","author":"Choi","year":"2020","journal-title":"Methods"},{"issue":"37","key":"10.1016\/j.biomaterials.2025.123138_bib299","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1039\/D2TB00709F","article-title":"Cell membrane-engineered nanoparticles for cancer therapy","volume":"10","author":"Liu","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"40","key":"10.1016\/j.biomaterials.2025.123138_bib300","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib301","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib302","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/pharmaceutics15020621","article-title":"Cell-membrane-coated nanoparticles for targeted drug delivery to the brain for the treatment of neurological diseases","volume":"15","author":"Li","year":"2023","journal-title":"Pharmaceutics"},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123138_bib303","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201909369","article-title":"Camouflaging nanoparticles with brain metastatic tumor cell membranes: a new strategy to traverse blood\u2013brain barrier for imaging and therapy of brain tumors","volume":"30","author":"Wang","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123138_bib304","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1021\/acsnano.9b04397","article-title":"Tumor-derived extracellular vesicles breach the intact blood\u2013brain barrier via transcytosis","volume":"13","author":"Morad","year":"2019","journal-title":"ACS Nano"},{"issue":"23","key":"10.1016\/j.biomaterials.2025.123138_bib305","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123138_bib306","first-page":"1546","article-title":"Highly penetrative liposome nanomedicine generated by a biomimetic strategy for enhanced cancer chemotherapy, Biomater","volume":"6","author":"Jia","year":"2018","journal-title":"Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib307","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1021\/acsnano.7b07716","article-title":"Cancer cell membrane-biomimetic nanoprobes with two-photon excitation and near-infrared emission for intravital tumor fluorescence imaging","volume":"12","author":"Lv","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123138_bib308","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biomaterials.2018.01.007","article-title":"NIR-responsive cancer cytomembrane-cloaked carrier-free nanosystems for highly efficient and self-targeted tumor drug delivery","volume":"159","author":"Zhang","year":"2018","journal-title":"Biomaterials"},{"issue":"47","key":"10.1016\/j.biomaterials.2025.123138_bib309","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201703969","article-title":"Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity","volume":"29","author":"Kroll","year":"2017","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123138_bib310","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201605398","article-title":"Multifaceted immunomodulatory nanoliposomes: reshaping tumors into vaccines for enhanced cancer immunotherapy","volume":"27","author":"Noh","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123138_bib311","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.10.021","article-title":"A biomimetic theranostic O2-meter for cancer targeted photodynamic therapy and phosphorescence imaging","volume":"151","author":"Li","year":"2018","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.biomaterials.2025.123138_bib312","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201704934","article-title":"Reassembly of 89Zr\u2010labeled cancer cell membranes into multicompartment membrane\u2010derived liposomes for PET\u2010trackable tumor\u2010targeted theranostics","volume":"30","author":"Yu","year":"2018","journal-title":"Adv. Mater."},{"issue":"28","key":"10.1016\/j.biomaterials.2025.123138_bib313","doi-asserted-by":"crossref","first-page":"15473","DOI":"10.1039\/D0NR04212A","article-title":"Tumor cellular membrane camouflaged liposomes as a non-invasive vehicle for genes: specific targeting toward homologous gliomas and traversing the blood\u2013brain barrier","volume":"12","author":"Zhao","year":"2020","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib314","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/acsnano.8b06556","article-title":"Phototheranostics: active targeting of orthotopic glioma using biomimetic proteolipid nanoparticles","volume":"13","author":"Jia","year":"2019","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123138_bib315","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1021\/jacs.2c13701","article-title":"Homotypic membrane-enhanced blood\u2013brain barrier crossing and glioblastoma targeting for precise surgical resection and photothermal therapy","volume":"145","author":"Zhang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"33","key":"10.1016\/j.biomaterials.2025.123138_bib316","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202203958","article-title":"Brain co\u2010delivery of temozolomide and cisplatin for combinatorial glioblastoma chemotherapy","volume":"34","author":"Zou","year":"2022","journal-title":"Adv. Mater."},{"issue":"51","key":"10.1016\/j.biomaterials.2025.123138_bib317","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202209239","article-title":"Brain\u2010targeting metastatic tumor cell membrane cloaked biomimetic nanomedicines mediate potent chemodynamic and RNAi combinational therapy of glioblastoma","volume":"32","author":"Zhang","year":"2022","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib318","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1038\/s41467-022-31799-y","article-title":"Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma","volume":"13","author":"Lu","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123138_bib319","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1021\/acsnano.7b09041","article-title":"Cancer cell membrane-coated adjuvant nanoparticles with mannose modification for effective anticancer vaccination","volume":"12","author":"Yang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123138_bib320","first-page":"418","article-title":"Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy","volume":"16","author":"Wang","year":"2022","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib321","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1080\/10717544.2021.1992038","article-title":"Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy","volume":"28","author":"Chen","year":"2021","journal-title":"Drug Deliv."},{"issue":"38","key":"10.1016\/j.biomaterials.2025.123138_bib322","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202004346","article-title":"Biomimetic nanocomposites cloaked with bioorthogonally labeled glioblastoma cell membrane for targeted multimodal imaging of brain tumors","volume":"30","author":"Duan","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123138_bib323","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.00113","article-title":"Neutrophil: a cell with many roles in inflammation or several cell types?","volume":"9","author":"Rosales","year":"2018","journal-title":"Front. Physiol."},{"issue":"22","key":"10.1016\/j.biomaterials.2025.123138_bib324","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706245","article-title":"Neutrophil-based drug delivery systems","volume":"30","author":"Chu","year":"2018","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib325","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1021\/acsnano.0c07973","article-title":"Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery","volume":"15","author":"Feng","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123138_bib326","article-title":"Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrity","volume":"20","author":"Tang","year":"2023","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.biomaterials.2025.123138_bib327","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jconrel.2023.08.020","article-title":"Inflammatory responsive neutrophil-like membrane-based drug delivery system for post-surgical glioblastoma therapy","volume":"362","author":"Chen","year":"2023","journal-title":"J. Control. Release"},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123138_bib328","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","article-title":"Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce immunomodulation for a synergistic and targeted antiglioblastoma activity","volume":"22","author":"Yin","year":"2022","journal-title":"Nano Lett."},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123138_bib329","doi-asserted-by":"crossref","first-page":"10142","DOI":"10.1021\/acsnano.3c13088","article-title":"Brain delivery of biomimetic phosphorus dendrimer\/antibody nanocomplexes for enhanced glioma immunotherapy via immune modulation of T cells and natural killer cells","volume":"18","author":"Peng","year":"2024","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib330","first-page":"529","article-title":"Macrophage membrane-coated nanocarriers co-modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in alzheimer's disease mice","volume":"6","author":"Han","year":"2021","journal-title":"Bioact. Mater."},{"issue":"25","key":"10.1016\/j.biomaterials.2025.123138_bib331","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202209785","article-title":"Recruiting T\u2010cells toward the brain for enhanced glioblastoma immunotherapeutic efficacy by co\u2010delivery of cytokines and immune checkpoint antibodies with macrophage\u2010membrane\u2010camouflaged nanovesicles","volume":"35","author":"Xu","year":"2023","journal-title":"Adv. Mater."},{"issue":"46","key":"10.1016\/j.biomaterials.2025.123138_bib332","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202408006","article-title":"ICAM-1-expressing extracellular vesicles enable sequential delivery barrier-breaking and microenvironment modulating for glioblastoma stem cell inhibition","volume":"34","author":"Liang","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib333","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/acsnano.2c09033","article-title":"Tumor\u2013antigen activated dendritic cell membrane-coated biomimetic nanoparticles with orchestrating immune responses promote therapeutic efficacy against glioma","volume":"17","author":"Ma","year":"2023","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib334","doi-asserted-by":"crossref","first-page":"11452","DOI":"10.1021\/acsnano.0c03824","article-title":"Natural-killer-cell-inspired nanorobots with aggregation-induced emission characteristics for near-infrared-II fluorescence-guided glioma theranostics","volume":"14","author":"Deng","year":"2020","journal-title":"ACS Nano"},{"issue":"44","key":"10.1016\/j.biomaterials.2025.123138_bib335","article-title":"A trojan-horse-like biomimetic nano-NK to elicit an immunostimulatory tumor microenvironment for enhanced GBM chemo-immunotherapy","volume":"19","author":"Zhang","year":"2023","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib336","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0882-4010(03)00090-1","article-title":"Outer membrane protein A and cytotoxic necrotizing factor-1 use diverse signaling mechanisms for escherichia coli K1 invasion of human brain microvascular endothelial cells","volume":"35","author":"Khan","year":"2003","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib337","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1038\/s41467-018-04637-3","article-title":"Caspr1 is a host receptor for meningitis-causing Escherichia coli","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib338","doi-asserted-by":"crossref","first-page":"418","DOI":"10.15698\/mic2018.09.647","article-title":"Escherichia coli hijack Caspr1 receptor to invade cerebral vascular and neuronal hosts","volume":"5","author":"Zhao","year":"2018","journal-title":"Microb. Cell"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib339","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1128\/IAI.00034-10","article-title":"NlpI contributes to Escherichia coli K1 strain RS218 interaction with human brain microvascular endothelial cells","volume":"78","author":"Teng","year":"2010","journal-title":"Infect. Immun."},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123138_bib340","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105854","article-title":"Biomimetic lipopolysaccharide-Free bacterial outer membrane-functionalized nanoparticles for brain-targeted drug delivery","volume":"9","author":"Chen","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2025.123138_bib341","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.144410","article-title":"Camouflaging multifunctional nanoparticles with bacterial outer membrane for augmented chemodynamic\/photothermal\/starvation\/chemo multimodal synergistic therapy of orthotopic glioblastoma","volume":"471","author":"He","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib342","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1038\/s41467-023-40280-3","article-title":"Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment","volume":"14","author":"Zou","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123138_bib343","article-title":"Aspirin curcumin ester loaded biomimetic nanodrug improves cognitive deficits in a mouse model of alzheimer's disease by regulating M1\/M2 microglial polarization","volume":"16","author":"Li","year":"2022","journal-title":"Mater. Today Adv."},{"issue":"29","key":"10.1016\/j.biomaterials.2025.123138_bib344","doi-asserted-by":"crossref","DOI":"10.1002\/ange.202304419","article-title":"Biomimetic nanocomposites camouflaged with hybrid cell membranes for accurate therapy of early\u2010stage glioma","volume":"135","author":"Chi","year":"2023","journal-title":"Angew. Chem."},{"issue":"26","key":"10.1016\/j.biomaterials.2025.123138_bib345","doi-asserted-by":"crossref","first-page":"31150","DOI":"10.1021\/acsami.3c03001","article-title":"Macrophage\u2013cancer hybrid membrane-camouflaged nanoplatforms for HIF-1\u03b1 gene silencing-enhanced sonodynamic therapy of glioblastoma","volume":"15","author":"Li","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biomaterials.2025.123138_bib346","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.133848","article-title":"Biomimetic neutrophil and macrophage dual membrane-coated nanoplatform with orchestrated tumor-microenvironment responsive capability promotes therapeutic efficacy against glioma","volume":"433","author":"Yin","year":"2022","journal-title":"Chem. Eng. J."},{"issue":"24","key":"10.1016\/j.biomaterials.2025.123138_bib347","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202306675","article-title":"Hybrid membrane-coated nanoparticles for precise targeting and synergistic therapy in alzheimer's disease","volume":"11","author":"Lin","year":"2024","journal-title":"Adv. Sci."},{"issue":"21","key":"10.1016\/j.biomaterials.2025.123138_bib348","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312897","article-title":"Blood\u2013brain barrier-penetrating and lesion-targeting nanoplatforms inspired by the pathophysiological features for synergistic ischemic stroke therapy","volume":"36","author":"Tang","year":"2024","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib349","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ceb.2009.03.007","article-title":"Exosomes\u2013vesicular carriers for intercellular communication","volume":"21","author":"Simons","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123138_bib350","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41582-018-0126-4","article-title":"Exosomes \u2014 beyond stem cells for restorative therapy in stroke and neurological injury","volume":"15","author":"Zhang","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biomaterials.2025.123138_bib351","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216077","article-title":"Exosomes; multifaceted nanoplatform for targeting brain cancers","volume":"557","author":"Mardi","year":"2023","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib352","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1021\/acsbiomaterials.3c00212","article-title":"Clinical theranostics trademark of exosome in glioblastoma metastasis","volume":"9","author":"Nag","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123138_bib353","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.3390\/ijms21124407","article-title":"Transport of extracellular vesicles across the blood-brain barrier: brain pharmacokinetics and effects of inflammation","volume":"21","author":"Banks","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib354","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1021\/acs.molpharmaceut.8b00985","article-title":"Cluster of differentiation 46 Is the major receptor in human blood\u2013brain barrier endothelial cells for uptake of exosomes derived from brain-metastatic melanoma cells (SK-Mel-28)","volume":"16","author":"Kuroda","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123138_bib355","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jconrel.2022.03.038","article-title":"Glioma-derived exosomes hijack the blood\u2013brain barrier to facilitate nanocapsule delivery via LCN2","volume":"345","author":"Yang","year":"2022","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib356","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/ejn.14974","article-title":"Heparan sulfate proteoglycan\u2010mediated dynamin\u2010dependent transport of neural stem cell exosomes in an in vitro blood\u2013brain barrier model","volume":"53","author":"Joshi","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.biomaterials.2025.123138_bib357","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","article-title":"Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease","volume":"287","author":"Qu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2025.123138_bib358","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.07.011","article-title":"Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain","volume":"142","author":"Yuan","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123138_bib359","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12195-016-0458-3","article-title":"Elucidation of exosome migration across the blood\u2013brain barrier model in vitro","volume":"9","author":"Chen","year":"2016","journal-title":"Cell. Mol. Bioeng."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123138_bib360","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1021\/acs.nanolett.8b04148","article-title":"Golden exosomes selectively target brain pathologies in neurodegenerative and neurodevelopmental disorders","volume":"19","author":"Perets","year":"2019","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib361","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-022-00894-3","article-title":"Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123138_bib362","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202310237","article-title":"Engineered microglia-exosomes coated highly twisting AIE photothermal agents to efficiently cross blood-brain-barrier for mild photothermal-immune checkpoint blockade therapy in glioblastoma","volume":"34","author":"Lin","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"21","key":"10.1016\/j.biomaterials.2025.123138_bib363","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202200353","article-title":"Functionalized macrophage exosomes with panobinostat and PPM1D\u2010siRNA for diffuse intrinsic pontine gliomas therapy","volume":"9","author":"Shan","year":"2022","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib364","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1021\/acsnano.2c10219","article-title":"Immune exosomes loading self-assembled nanomicelles traverse the blood\u2013brain barrier for chemo-immunotherapy against glioblastoma","volume":"17","author":"Cui","year":"2023","journal-title":"ACS Nano"},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123138_bib365","doi-asserted-by":"crossref","first-page":"14576","DOI":"10.1021\/acsami.9b00893","article-title":"Ultrasound facilitates naturally equipped exosomes derived from macrophages and blood serum for orthotopic glioma treatment","volume":"11","author":"Bai","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib366","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.1038\/s41598-019-44569-6","article-title":"Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood\u2013brain barrier penetration","volume":"9","author":"Khongkow","year":"2019","journal-title":"Sci. Rep."},{"issue":"n\/a","key":"10.1016\/j.biomaterials.2025.123138_bib367","article-title":"Engineered brain-targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma","volume":"a","author":"Yang","year":"2024","journal-title":"Exploration n\/"},{"key":"10.1016\/j.biomaterials.2025.123138_bib368","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biomaterials.2018.06.029","article-title":"NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo","volume":"178","author":"Jia","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123138_bib369","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jconrel.2022.03.036","article-title":"Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy","volume":"345","author":"Rehman","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib370","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41551-019-0485-1","article-title":"Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation","volume":"4","author":"Yang","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2025.123138_bib371","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jconrel.2022.03.035","article-title":"Translation of focused ultrasound for blood-brain barrier opening in glioma","volume":"345","author":"Brighi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2025.123138_bib372","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1007049806660","article-title":"Osmotic opening of the blood\u2013brain barrier: principles, mechanism, and therapeutic applications","volume":"20","author":"Rapoport","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib373","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/02656736.2020.1783461","article-title":"The effect of thermal therapy on the blood-brain barrier and blood-tumor barrier","volume":"37","author":"Patel","year":"2020","journal-title":"Int. J. Hyperthermia"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib374","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15594","article-title":"Magnetic forces enable controlled drug delivery by disrupting endothelial cell-cell junctions","volume":"8","author":"Qiu","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123138_bib375","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/17425247.2024.2369765","article-title":"Brain delivery enabled by transient blood\u2013brain barrier disruption induced by regadenoson: a PET imaging study","volume":"21","author":"Hosten","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib376","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.neuroscience.2009.04.004","article-title":"Permeability of the blood-brain barrier depends on brain temperature","volume":"161","author":"Kiyatkin","year":"2009","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib377","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1039\/D2NR05062E","article-title":"Mechanobiological modulation of blood\u2013brain barrier permeability by laser stimulation of endothelial-targeted nanoparticles","volume":"15","author":"Li","year":"2023","journal-title":"Nanoscale"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123138_bib378","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/pharmaceutics13020169","article-title":"Non-invasive low pulsed electrical fields for inducing BBB disruption in mice\u2014feasibility demonstration","volume":"13","author":"Sharabi","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2\u20134","key":"10.1016\/j.biomaterials.2025.123138_bib379","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/ejnm-2012-0010","article-title":"Limitations and niches of the active targeting approach for nanoparticle drug delivery","volume":"4","author":"Chen","year":"2012","journal-title":"Eur. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2025.123138_bib380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.02.040","article-title":"Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: challenges and opportunities","volume":"277","author":"Belfiore","year":"2018","journal-title":"J. Control. Release"},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123138_bib381","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1039\/C6CS00076B","article-title":"Blood\u2013brain barrier shuttle peptides: an emerging paradigm for brain delivery","volume":"45","author":"Oller-Salvia","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2025.123138_bib382","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s00726-011-0979-y","article-title":"Identification of peptide sequences that target to the brain using in vivo phage display","volume":"42","author":"Li","year":"2012","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib383","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1038\/s41467-018-05384-1","article-title":"Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption","volume":"9","author":"Guan","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib384","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41551-019-0434-z","article-title":"Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice","volume":"3","author":"Wen","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib385","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12987-021-00257-0","article-title":"Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size","volume":"18","author":"Faresj\u00f6","year":"2021","journal-title":"Fluids Barriers CNS"},{"issue":"183","key":"10.1016\/j.biomaterials.2025.123138_bib386","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005338","article-title":"Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier","volume":"5","author":"Couch","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123138_bib387","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4049\/immunohorizons.2300102","article-title":"Recent advances in the development of monoclonal antibodies and next-generation antibodies","volume":"7","author":"Singh","year":"2023","journal-title":"ImmunoHorizons"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123138_bib388","doi-asserted-by":"crossref","first-page":"17080","DOI":"10.1021\/acsnano.1c03800","article-title":"Cell membrane-coated mimics: a methodological approach for fabrication, characterization for therapeutic applications, and challenges for clinical translation","volume":"15","author":"Chugh","year":"2021","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123138_bib389","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202400012","article-title":"Cell membrane-coated nanoparticles: a new frontier in immunomodulation","volume":"4","author":"Desai","year":"2024","journal-title":"Adv. NanoBiomed Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123138_bib390","doi-asserted-by":"crossref","first-page":"284","DOI":"10.14348\/molcells.2022.2033","article-title":"Manufacturing therapeutic exosomes: from bench to industry","volume":"45","author":"Ahn","year":"2022","journal-title":"Mol. Cells"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib391","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1021\/acsbiomaterials.0c00743","article-title":"Effect of nanoparticle composition, size, shape, and stiffness on penetration across the blood\u2013brain barrier","volume":"6","author":"Brown","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123138_bib392","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41565-021-00870-y","article-title":"Computationally guided high-throughput design of self-assembling drug nanoparticles","volume":"16","author":"Reker","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123138_bib393","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa1279","article-title":"In vivo phage display: identification of organ-specific peptides using deep sequencing and differential profiling across tissues","volume":"49","author":"Pleiko","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123138_bib394","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1021\/acsnano.2c11675","article-title":"Aptamer nanoconstructs crossing human blood\u2013brain barrier discovered via microphysiological system-based SELEX technology","volume":"17","author":"Choi","year":"2023","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib395","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3233\/JAD-170255","article-title":"Of mice and men: comparative analysis of neuro-inflammatory mechanisms in human and mouse using cause-and-effect models","volume":"59","author":"Kodamullil","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123138_bib396","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00604-023-06165-4","article-title":"Humanized brain organoids-on-chip integrated with sensors for screening neuronal activity and neurotoxicity","volume":"191","author":"Saglam-Metiner","year":"2024","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.biomaterials.2025.123138_bib397","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122143","article-title":"Functional bioengineered tissue models of neurodegenerative diseases","volume":"298","author":"Mullis","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123138_bib398","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1039\/D4LC00633J","article-title":"Real-time monitoring of a 3D blood-brain barrier model maturation and integrity with a sensorized microfluidic device","volume":"24","author":"Ceccarelli","year":"2024","journal-title":"Lab Chip"},{"key":"10.1016\/j.biomaterials.2025.123138_bib399","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114816","article-title":"An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines","volume":"196","author":"P\u00e9rez-L\u00f3pez","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123138_bib400","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s10462-021-10058-4","article-title":"Machine learning in drug discovery: a review","volume":"55","author":"Dara","year":"2022","journal-title":"Artif. Intell. Rev."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225000572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225000572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:02:32Z","timestamp":1777568552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225000572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":400,"alternative-id":["S0142961225000572"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123138","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced nanoparticle engineering for precision therapeutics of brain diseases","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123138"}}